Credicorp hits its Q2 earnings release today with positioning that remains relaxed — but the analyst community has grown more fractured since the last preview, and the stock has slipped further from its highs.
The options market has barely moved since the August 10 preview. The put/call ratio is 0.27, still fractionally above its 20-day average of 0.26 and well below its 52-week high of 5.86 — call volume continues to dominate, and traders are not paying up for downside protection. Borrow conditions remain extraordinarily loose: availability is running near 7,862%, a slight tightening from the near-uncapped readings earlier in the week but still far above the 52-week floor of around 2,929%. Short interest has continued to fall, dropping another 2.4% on the week to roughly 1.02 million shares — a 25% decline over the past month. Cost to borrow is just 0.48%, having eased 16% on the week. Nothing in the lending market suggests meaningful short-side conviction.
The more interesting tension lies in what analysts disagree about. Goldman Sachs raised its target to $374 in mid-July — almost exactly where the stock now trades at $375.14 — while holding a Neutral rating, implying the Street's most prominent cautious voice sees essentially no room left to run. Morgan Stanley took the opposite view in June, upgrading to Overweight with a $480 target, the highest on the Street. JP Morgan downgraded to Neutral in mid-June, keeping its $415 target but pulling its conviction. The mean analyst target sits at $408, a roughly 9% premium to today's close — modest implied upside by emerging-market banking standards. Valuation offers limited drama: the stock trades at 11.5x trailing earnings and 2.25x book, both having compressed modestly over the past month as the price pulled back.
One institutional signal worth noting is Capital Research and Management adding over 2.1 million shares as recently as July 31 — a large move for a stock with a relatively concentrated ownership base. That contrasts with the CEO of a major subsidiary selling $1.1 million worth of stock in early June, though the trade's significance score was low. The stock's EPS surprise factor ranks in the 98th percentile across the ORTEX universe, meaning Credicorp has a strong track record of beating estimates. The most comparable recent reaction — Q1 results in May — saw the stock drop 7.3% on the day before recovering to close the five-day window up 2%.
Today's print will ultimately test whether Credicorp's fundamentals can close the gap between Goldman's skepticism and Morgan Stanley's conviction — and whether a high EPS-surprise track record holds up at a valuation that leaves little margin for disappointment.
See the live data behind this article on ORTEX.
Open BAP on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
